Rankings
▼
Calendar
PMVP Q2 2022 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PMVP
PMV Pharmaceuticals, Inc.
$88M
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18M
Net Income
-$17M
EPS (Diluted)
$-0.38
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$17M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$301M
Total Liabilities
$24M
Stockholders' Equity
$277M
Cash & Equivalents
$87M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$18M
-$13M
-37.0%
Net Income
-$17M
-$13M
-34.5%
← FY 2022
All Quarters
Q3 2022 →